Enanta Pharmaceuticals | ENTA - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 384.69B 19.14B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Incyte USD 18.73B 660M 2026-03
Insmed USD 35.3B 1.82B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 1.12B 989M 2026-07
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Merck USD 297.1B 35.84B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.28B 30M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03